ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
Nektar Therapeutics

Nektar Therapeutics (0UNL)

47,18
0,00
(0,00%)
Fermé 08 Février 5:30PM

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Statistiques et détails clés

Dernier
47,18
Prix Achat
0,00
Prix Vente
0,00
Volume échangé
0,00
0,00 Fourchette du Jour 0,00
47,18 Plage de 52 semaines 47,18
Cap du marché
Clôture Veille
47,18
Ouverture
-
Dernière Transaction
(O)
Dernière heure de transaction
Volume financier
-
VWAP
-
Volume moyen (3 m)
9 609
Actions en circulation
190 771 000
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-0,47
Bénéfice par action (BPA)
-1,45
Chiffre d'affairess
90,12M
Bénéfice net
-276,06M

À propos de Nektar Therapeutics

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Site Web
Siège social
Wilmington, Delaware, USA
Fondé
-
Nektar Therapeutics est coté dans le secteur Pharmaceutical Preparations de la London Stock Exchange avec le ticker 0UNL. Le dernier cours de clôture d'Nektar Therapeutics était de US$47,18. Au cours de la dernière année, les actions de Nektar Therapeutics ont été négociées dans une fourchette de prix de US$ 47,18 à US$ 47,18.

Nektar Therapeutics compte actuellement 190 771 000 actions en circulation. La capitalisation boursière d'Nektar Therapeutics est de US$9,00 milliard. Nektar Therapeutics a un ratio cours/bénéfice (ratio PE) de -0.47.

0UNL Dernières nouvelles

Form 8.3 - The Vanguard Group, Inc.: Nektar Therapeutics, Inc

The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: Nektar Therapeutics, Inc 11-Oct-2022 / 14:01 GMT/BST Dissemination of a Regulatory Announcement, transmitted by EQS Group. The...

Norges Bank - Form 8.3 - Nektar Therapeutics, Inc

Norges Bank - Form 8.3 - Nektar Therapeutics, Inc PR Newswire London, October 11                                                                                                                    ...

Norges Bank Form 8.3 - Nektar Therapeutics, Inc

L FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1...

Form 8 (OPD) Nektar Therapeutics, Inc.

L FORM 8.3 OPENING DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1. KEY INFORMATION (a) Full...

Form 8.3 - The Vanguard Group, Inc.: Nektar Therapeutics, Inc

The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: Nektar Therapeutics, Inc 10-Oct-2022 / 14:21 GMT/BST Dissemination of a Regulatory Announcement, transmitted by EQS Group. The...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10047.1847.1847.1815747.18DE
40047.1847.1847.18245747.18DE
120047.1847.1847.18960947.18DE
260047.1847.1847.18712247.18DE
520047.1847.1847.18927947.18DE
1560047.1847.1847.18693447.18DE
2600047.1847.1847.18425647.18DE

0UNL - Frequently Asked Questions (FAQ)

What is the current Nektar Therapeutics share price?
The current share price of Nektar Therapeutics is US$ 47,18
How many Nektar Therapeutics shares are in issue?
Nektar Therapeutics has 190 771 000 shares in issue
What is the market cap of Nektar Therapeutics?
The market capitalisation of Nektar Therapeutics is USD 9B
What is the 1 year trading range for Nektar Therapeutics share price?
Nektar Therapeutics has traded in the range of US$ 47,18 to US$ 47,18 during the past year
What is the PE ratio of Nektar Therapeutics?
The price to earnings ratio of Nektar Therapeutics is -0,47
What is the cash to sales ratio of Nektar Therapeutics?
The cash to sales ratio of Nektar Therapeutics is 1,44
What is the reporting currency for Nektar Therapeutics?
Nektar Therapeutics reports financial results in USD
What is the latest annual turnover for Nektar Therapeutics?
The latest annual turnover of Nektar Therapeutics is USD 90,12M
What is the latest annual profit for Nektar Therapeutics?
The latest annual profit of Nektar Therapeutics is USD -276,06M
What is the registered address of Nektar Therapeutics?
The registered address for Nektar Therapeutics is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Nektar Therapeutics website address?
The website address for Nektar Therapeutics is www.nektar.com
Which industry sector does Nektar Therapeutics operate in?
Nektar Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
ASTAscent Resources Plc
1,90p
(100,00%)
591,55k
NTQEnteq Technologies Plc
2,85p
(58,33%)
17,97M
THRUThruvision Group Plc
3,25p
(30,00%)
307,66k
IMMImmupharma Plc
4,98p
(27,69%)
14,75M
GEXGeorgina Energy Plc
6,375p
(24,39%)
5,16M
BELLBelluscura Plc
1,875p
(-71,15%)
13,68M
APQApq Global Limited
2,00p
(-69,23%)
60,87k
IOMIomart Group Plc
45,40p
(-23,57%)
1,76M
SYMESupply@me Capital Plc
0,002p
(-20,00%)
736,23M
PRMProteome Sciences Plc
3,50p
(-17,45%)
50,06k
SYMESupply@me Capital Plc
0,002p
(-20,00%)
736,23M
ORCPOracle Power Plc
0,017p
(-14,14%)
523,64M
CPAICapai Plc
0,0475p
(7,95%)
355,25M
NTVONativo Resources Plc
0,0017p
(0,00%)
347,62M
MSMNMosman Oil And Gas Limited
0,04p
(2,56%)
263,67M
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock